SlideShare a Scribd company logo
Germany
SIRTRARASASAN BHARATHIDHASAN
1319
Deutschland
• Germany is a densely populated and highly industrialized country
with more than 82 million inhabitants. The life expectancy at birth is
77.6 years for males and 82.8 years for females. The percentage of
the population aged 65 years or more is rising. Germany does not
have a national health care system. The health care system is
administered through several autonomous bodies and associations
such as the statutory health insurance system (GKV), the
association of physicians under contract with the GKV, and the
hospitals association.
Indicators Values
POPULATION 82,727,000
% of population aged 0–14 years 13
% of population aged 65+ years 21
Crude death rate per 1000 population 11
Estimated infant mortality per 1000 live births (world health report) 3
Estimated life expectancy (world health report) 81
Life expectancy at birth (years), females 83
Life expectancy at birth (years), males 78
Hospital beds per 100 000 828
Physicians per 100 000 405
Indicators Values
SDR all causes, all ages, per 100 000 564
SDR, diseases of circulatory system, all ages, per 100 000 200
SDR, external causes of injury and poisoning, all ages, per 100 000 28
SDR, malignant neoplasms, all ages, per 100 000 157
Total health expenditure as % of GDP, WHO estimates 11
Total expenditure on health per capita 4812
All the details mentioned above are the extracts from a survey taken by Robert Koch Institute(RKI) in
2014
TOP 10 CAUSES OF DEATH
per 10000 population
• Disease rate global rank
• Coronary Heart Disease 62.93 133
• Lung Cancers 27.78 30
• Stroke 27.32 163
• Breast Cancer 21.84 32
• Prostate Cancer 15.98 93
• Colon-Rectum Cancers 15.17 41
• Hypertension 15.05 04
• Alzheimers/Dementia 13.39 25
• Diabetes Mellitus 11.43 138
• Influenza and Pneumonia 9.86 189
Social Diseases
• What is a Social Disease?
• A disease having it’s highest incidence among socioeconomic group
of a country predisposed to it by a given set of adverse
living or working conditions
• Example:Prevalance of cancers and radiation related adverse
effects in regions near Chernobyl and Fukushima
• Simply it refers to regional diseases provoked by adverse
conditions.
PREVALENCE OF HIV IN GERMANY
• Diagnoses of new HIV infections in Germany rose by 20% in the first half of 2014
compared with the first half of 2010, according to the latest figures from the Robert
Koch Institute, Germany's centre for public health and disease control. Gay and
bisexual men accounted for almost 60% of these new HIV diagnoses, a 30% rise from
four years ago.
• With a population of 82.5 million, Germany is Europe's most populous nation.
Historically, HIV prevention has been relatively successful and new HIV diagnoses
have tended to total under 2,000 each year for the past decade. Even though in
2014 new HIV diagnoses totalled 2,058 - the highest since 2002 - this compares with
7,000 new HIV diagnoses in 2003 in the United Kingdom, the third most populous
country in Europe with around 60 million inhabitants
• The Institute also reports on the cities with the highest HIV incidence
rates between July 2004 and June 2005. Cologne, with an incidence
rate of 12.42 per 100,000 population had the highest rate. However, the
highest absolute numbers were seen in Germany's two biggest cities,
Berlin and Hamburg, which had incidence rates of 10 per 100,000 and
9.57 per 100,000, respectively. Other cities with high HIV incidence
included Munich, Frankfurt and Düsseldorf.
• According to the latest estimate, there were a total of 436,500 new cancer
cases in Germany in 2004. The most common cancer in men is prostate cancer
with over 58,000 new cases per annum, followed by colorectal and lung cancer.
In women, breast cancer remains the most common cancer with an estimated
57,000 new cases every year, also followed by colorectal cancer. These and
further findings on selected cancer sites can be found in the current brochure
on "Cancer in Germany“ which is regularly published by rki.
• In addition, the RKI made cancer-prevalence estimates and calculated current
morbidity and mortality risks at the federal level for the first time
• According to these figures, the 5-year partial prevalence - i.e. the total
number of cancer patients diagnosed over the past five years who are currently
still living - exceeds 600,000 in men; the figure is about the same among
women.
Prevalence of Cancers in Germany
• Here, too, the most common cancers are prostate cancer in men and breast
cancer in women. The lifetime risk of developing cancer, which is more related
to the individual, is estimated to be higher among men (48.5%) than among
women (40.3%)
• In roughly rounded figures, therefore, about every day, a person in Germany
develops cancer in the course of their lives
• One in four men and one in five women die of cancer.
• In Germany, crude death rates from cancer were in excess of 300
deaths per 100 000 inhabitants in the regions of Sachsen-Anhalt,
Chemnitz, Saarland, Mecklenburg-Vorpommern, Arnsberg and
Düsseldorf
• By contrast, a relatively low crude death rate was recorded in the
southern German region of Tübingen (220 deaths per 100 000
inhabitants).
• Across the EU Member States, there was a large cluster of
relatively high death rates from breast cancer in the centre of the
EU covering much of Germany, Denmark, the Benelux countries,
eastern France, northern Italy, eastern Austria and western
Hungary; high rates were also recorded in some parts of the
United Kingdom.
• The HIV epidemic in Germany can be characterized as a concentrated
epidemic. The most affected population groups are
• MSM (estimated number of MSM living with HIV by the end of 2011:
46,500)
• Migrants originating from HIV high prevalence countries (estimated
number of migrants living with HIV by end of 2011: 9,000)
• IDU (estimated number of IDU living with HIV by end of 2011: 6,800
[including former IDU])
HIV INFECTION
Men 59000
Women 14000
Among these: Children 200
……by mode of transmission
Homosexual contact 46500
Heterosexual contact 10500
IV drug use 6500
Blood transfusion 450
Mother to Children 420
Persons living with HIV 73000
• Currently, the incidence is highest among MSM. It is estimated that
74 % of the HIV infections acquired in Germany are through male
homosexual contact, 20% through heterosexual contact, 6%
associated with injecting drug use. Less than 1% of infections are
due to mother-to-child transmission.
• The number of newly diagnosed HIV infections in IDU in Germany
has been continuously declining since 1997.
• Data modelling suggests that HIV incidence among MSM started to
decline as early as 2007. HIV prevalence among this group is
estimated between 5.0% and 7.5%
• Approximately half of the heterosexually acquired HIV infections
in Germany are reported in migrants originating from high
prevalence countries with a generalized epidemic (predominantly
from countries in western Sub-Saharan Africa)
• Over the past 50 years, the reduction of mortality from CVD in
Germany has followed a similar trend as the OECD average,
reaching 310 per 100 000 population, 4% higher than the OECD
average of 299 in 2011
• the number of patients with end-stage kidney failure (ESKF),
often caused by diabetes and hypertension, at 87 per 100 000
population in 2000, is also lower than the OECD average of 101 in
2011
CARDIOVASCULAR DISEASES
• The rate of smoking, one of the risk factors for CVD, was 21.9% for
adults in 2011, higher than the OECD average of 20.9%, and youth
smoking was 22.4%, compared to an OECD average of 19.5%, but the
most recent national data show improvements (20.9% and 18.5%
respectively in 2013).
• The rate of overweight, at 36.7%, is also higher than the OECD
average of 34.6%. On the other hand, the rate of obesity, at 14.7%, is
much lower than the OECD averages of 18.0% but it is increasing
(15.7% in 2013).
• The reported prevalence of high cholesterol levels and high blood
pressure is 24.6% and 26.0% each, again higher than the OECD
average of 18.0% and 25.6%, respectively.
• Spending on prevention, however, is 3.4% of the current health
expenditure and higher than the OECD average of 2.9%.
DISABLED PERSONS IN GERMANY
• In 2013, 10.2 million people with an officially recognised disability - on
the basis of microcensus results - were living in Germany
• On average, more than one in eight inhabitants (13%) was disabled
• More than half of them (52%) were men.
• The majority, that is, roughly 7.5 million people were severely
disabled, while 2.7 million people suffered from a moderate disability
Severely disabled people (in 2013) 7,548,965
Men 51.0%
Women 49%
>65 Years 53.4%
Age groups Disability rate
1-20 years of age 8%
20-30 6%
30-45 15%
45-65 6.8%
>65 25%
Overview of the facilities, organizations and support
available for people with disabilities in Germany...
• German law (Grundgesetz) forbids discrimination on the basis of physical or mental
disability.
• The Social Welfare Code IX (SGBIX), which came in to force in April 2001, is based
on the idea of equal opportunities and participation rather than merely welfare
• It focuses on rehabilitation and access for disabled people and stipulates levels of
support depending on measurement of the degree of disability
• According to the German Federal Statistical Office, or Destatis,
the impact of the disability on the participation in the life of
society is graded from 20 to 100.
• People are classified as severely disabled in Germany if a pension
office has determined a degree of disablement of 50 or more.
• As easily disabled persons are referred to with a degree of
disability of less than 50.
There is a great deal of support available to disabled people
(behinderter Menschen) in Germany, from general counselling to
specific institutions such as:
• Advice centres
• Early support centres for children (Frühförderung)
• Integrated kindergartens
• Special kindergartens (Sonderkindergarten or Förderkindergarten)
• Special Schools (Sonderschulen)
• Special professional schools (Berufsschulen), for instance for deaf pupils
• Apprenticeships for visually impaired and deaf people
(Ausbildungsplaetze)
• Employment integration support
• Care and accommodation grants for disabled people
• Workshops for disabled people (Werkstätten für behinderte
Menschen)
• Transport services (Fahrdienste)
To conclude……
• Approximately 15% of the NATION’S INCOME is used for HEALTH CARE
MANAGENMENT every year
• At present around 2.2 million people are employed in outpatient care
• In Germany, there are currently more than 200 inpatient hospices, more than
250 palliative units in hospitals and around 1,500 outpatient hospice services
• In 2013 health expenses amounted to EUR 314.9 billion. The largest item is made
up of medical followed by care services
• In an international comparison Germany ranges with per capita expenses of
around EUR 3,800 per year for health in the LIST OF EUROPEAN NATIONS Health
care is one of the industries with the highest sales revenues in Germany. 6.1
million employees worked in the health economy (including wellness, fitness
etc.) in 2012
References:
• Germany’s health profile -http://www.worldlifeexpectancy.com/country-health-
profile/Germany
• Causes of deaths in Germany-
https://www.destatis.de/EN/FactsFigures/SocietyState/Health/CausesDeath/Causes
Death.html
• Prevalence of various diseases in Germany-
http://www.healthdatanavigator.eu/national/Germany
• People with disabilities in Germany-https://www.angloinfo.com/germany/how-
to/germany-healthcare-people-with-disabilities
• http://www.bmas.de/EN/Our-Topics/Participation-of-Persons-with-
Disabilities/disability-policy.html
• Robert Koch Institute-
http://www.rki.de/EN/Content/Health_Monitoring/health_monitoring_node.html
Germany-Health statistics

More Related Content

What's hot

Better health for Europe - equitable and sustainable
Better health for Europe - equitable and sustainableBetter health for Europe - equitable and sustainable
Better health for Europe - equitable and sustainable
WHO Regional Office for Europe
 
Report of the Regional Director on the work of WHO in the European Region
Report of the Regional Director on the work of WHO in the European RegionReport of the Regional Director on the work of WHO in the European Region
Report of the Regional Director on the work of WHO in the European Region
WHO Regional Office for Europe
 
PREVALENCE OF NON-COMMUNICABLE DISEASE
PREVALENCE OF NON-COMMUNICABLE DISEASEPREVALENCE OF NON-COMMUNICABLE DISEASE
PREVALENCE OF NON-COMMUNICABLE DISEASE
Public Health Update
 
Epidemiology of Non Communicable Diseases (NCDs)
Epidemiology of Non Communicable Diseases (NCDs)Epidemiology of Non Communicable Diseases (NCDs)
Epidemiology of Non Communicable Diseases (NCDs)
Prabesh Ghimire
 
NON COMMUNICABLE DISEASE komal
NON COMMUNICABLE DISEASE komalNON COMMUNICABLE DISEASE komal
NON COMMUNICABLE DISEASE komal
Dr.Rani Komal Lata
 
Role of peripheral health centres in non communicable diseases
Role   of  peripheral  health centres in non communicable diseasesRole   of  peripheral  health centres in non communicable diseases
Role of peripheral health centres in non communicable diseases
SHAFI UR RAHMAN KHAN
 
ReFlections Spring 2015
ReFlections Spring 2015ReFlections Spring 2015
ReFlections Spring 2015
H Henly
 
Tuberculosis global facts
Tuberculosis global factsTuberculosis global facts
Tuberculosis global facts
Robson Peixoto
 
Contemporary health policy context in Europe: some opportunities and challenges
Contemporary health policy context in Europe: some opportunities and challenges Contemporary health policy context in Europe: some opportunities and challenges
Contemporary health policy context in Europe: some opportunities and challenges
WHO Regional Office for Europe
 
Presentation - The global and regional policy context: Implications for Cyprus
Presentation - The global and regional policy context: Implications for CyprusPresentation - The global and regional policy context: Implications for Cyprus
Presentation - The global and regional policy context: Implications for Cyprus
WHO Regional Office for Europe
 
2009 aids epidemic update
2009 aids epidemic update2009 aids epidemic update
2009 aids epidemic update
Pim Piepers
 

What's hot (11)

Better health for Europe - equitable and sustainable
Better health for Europe - equitable and sustainableBetter health for Europe - equitable and sustainable
Better health for Europe - equitable and sustainable
 
Report of the Regional Director on the work of WHO in the European Region
Report of the Regional Director on the work of WHO in the European RegionReport of the Regional Director on the work of WHO in the European Region
Report of the Regional Director on the work of WHO in the European Region
 
PREVALENCE OF NON-COMMUNICABLE DISEASE
PREVALENCE OF NON-COMMUNICABLE DISEASEPREVALENCE OF NON-COMMUNICABLE DISEASE
PREVALENCE OF NON-COMMUNICABLE DISEASE
 
Epidemiology of Non Communicable Diseases (NCDs)
Epidemiology of Non Communicable Diseases (NCDs)Epidemiology of Non Communicable Diseases (NCDs)
Epidemiology of Non Communicable Diseases (NCDs)
 
NON COMMUNICABLE DISEASE komal
NON COMMUNICABLE DISEASE komalNON COMMUNICABLE DISEASE komal
NON COMMUNICABLE DISEASE komal
 
Role of peripheral health centres in non communicable diseases
Role   of  peripheral  health centres in non communicable diseasesRole   of  peripheral  health centres in non communicable diseases
Role of peripheral health centres in non communicable diseases
 
ReFlections Spring 2015
ReFlections Spring 2015ReFlections Spring 2015
ReFlections Spring 2015
 
Tuberculosis global facts
Tuberculosis global factsTuberculosis global facts
Tuberculosis global facts
 
Contemporary health policy context in Europe: some opportunities and challenges
Contemporary health policy context in Europe: some opportunities and challenges Contemporary health policy context in Europe: some opportunities and challenges
Contemporary health policy context in Europe: some opportunities and challenges
 
Presentation - The global and regional policy context: Implications for Cyprus
Presentation - The global and regional policy context: Implications for CyprusPresentation - The global and regional policy context: Implications for Cyprus
Presentation - The global and regional policy context: Implications for Cyprus
 
2009 aids epidemic update
2009 aids epidemic update2009 aids epidemic update
2009 aids epidemic update
 

Viewers also liked

Wepdd104
Wepdd104Wepdd104
Wepdd104
Mohamed Rafique
 
Global Commission on HIV and the Law: Risks, Rights and Health
Global Commission on HIV and the Law: Risks, Rights and HealthGlobal Commission on HIV and the Law: Risks, Rights and Health
Global Commission on HIV and the Law: Risks, Rights and Health
UNDP Eurasia
 
Wesat2104
Wesat2104Wesat2104
Wesat2104
Mohamed Rafique
 
Cultural traditions and policy in germany
Cultural traditions and policy in germanyCultural traditions and policy in germany
Cultural traditions and policy in germany
IPCB2011
 
health insurance in germany and indonesia
health insurance in germany and indonesiahealth insurance in germany and indonesia
health insurance in germany and indonesia
nivtrip
 
National health policy
National health policyNational health policy
National health policy
chanlal
 
introduction-to-health-policy
introduction-to-health-policyintroduction-to-health-policy
introduction-to-health-policy
Nayyar Kazmi
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
Malini Rajan
 

Viewers also liked (8)

Wepdd104
Wepdd104Wepdd104
Wepdd104
 
Global Commission on HIV and the Law: Risks, Rights and Health
Global Commission on HIV and the Law: Risks, Rights and HealthGlobal Commission on HIV and the Law: Risks, Rights and Health
Global Commission on HIV and the Law: Risks, Rights and Health
 
Wesat2104
Wesat2104Wesat2104
Wesat2104
 
Cultural traditions and policy in germany
Cultural traditions and policy in germanyCultural traditions and policy in germany
Cultural traditions and policy in germany
 
health insurance in germany and indonesia
health insurance in germany and indonesiahealth insurance in germany and indonesia
health insurance in germany and indonesia
 
National health policy
National health policyNational health policy
National health policy
 
introduction-to-health-policy
introduction-to-health-policyintroduction-to-health-policy
introduction-to-health-policy
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 

Similar to Germany-Health statistics

Social diseases germany
Social diseases germanySocial diseases germany
Social diseases germany
Mahesh Kumar
 
Wtbd 2015 final_eng
Wtbd 2015 final_engWtbd 2015 final_eng
Wtbd 2015 final_eng
WHO Regional Office for Europe
 
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
European Centre for Disease Prevention and Control
 
How to improve the health of the Polish population. Health 2020 – the Europea...
How to improve the health of the Polish population. Health 2020 – the Europea...How to improve the health of the Polish population. Health 2020 – the Europea...
How to improve the health of the Polish population. Health 2020 – the Europea...
WHO Regional Office for Europe
 
Aids awareness
Aids awarenessAids awareness
Aids awareness
마 이환
 
Seminar on hiv
Seminar on hivSeminar on hiv
Seminar on hiv
sirjana Tiwari
 
seminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdfseminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdf
mZOn2
 
HIV AIDS
HIV AIDSHIV AIDS
Presentation: Launch of the Knowledge Hub on Health and Migration
Presentation: Launch of the Knowledge Hub on Health and MigrationPresentation: Launch of the Knowledge Hub on Health and Migration
Presentation: Launch of the Knowledge Hub on Health and Migration
WHO Regional Office for Europe
 
Global tuberculosis report 2013 supplement
Global tuberculosis report 2013 supplementGlobal tuberculosis report 2013 supplement
Global tuberculosis report 2013 supplement
Drbharatgoswami Bipinbhai
 
Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...
WHO Regional Office for Europe
 
noncommunicablediseasespro1-180101054815.pdf
noncommunicablediseasespro1-180101054815.pdfnoncommunicablediseasespro1-180101054815.pdf
noncommunicablediseasespro1-180101054815.pdf
KristineHP
 
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxWORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
anjalatchi
 
global health11.pptxglopal health 1234556666666
global health11.pptxglopal health 1234556666666global health11.pptxglopal health 1234556666666
global health11.pptxglopal health 1234556666666
NameNoordahsh
 
World TB Day 2017 - presentation
World TB Day 2017 - presentationWorld TB Day 2017 - presentation
World TB Day 2017 - presentation
WHO Regional Office for Europe
 
Presentation – The WHO European Region's public health response to refugee an...
Presentation – The WHO European Region's public health response to refugee an...Presentation – The WHO European Region's public health response to refugee an...
Presentation – The WHO European Region's public health response to refugee an...
WHO Regional Office for Europe
 
Cmoathensrdkeynotespeechinfectdiseasesedited 140306043900-phpapp02
Cmoathensrdkeynotespeechinfectdiseasesedited 140306043900-phpapp02Cmoathensrdkeynotespeechinfectdiseasesedited 140306043900-phpapp02
Cmoathensrdkeynotespeechinfectdiseasesedited 140306043900-phpapp02
hetalmalaviya
 
6249919.ppt
6249919.ppt6249919.ppt
6249919.ppt
Esam43
 
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO
OVEARVIEW  OF NON-COMMUNICABLE DISEASES  IN LEOTHO   OVEARVIEW  OF NON-COMMUNICABLE DISEASES  IN LEOTHO
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO
SEJOJO PHAAROE
 
Infectious disease control as part of prevention of cancer in developing coun...
Infectious disease control as part of prevention of cancer in developing coun...Infectious disease control as part of prevention of cancer in developing coun...
Infectious disease control as part of prevention of cancer in developing coun...
Jean Jacques Bernatas
 

Similar to Germany-Health statistics (20)

Social diseases germany
Social diseases germanySocial diseases germany
Social diseases germany
 
Wtbd 2015 final_eng
Wtbd 2015 final_engWtbd 2015 final_eng
Wtbd 2015 final_eng
 
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
 
How to improve the health of the Polish population. Health 2020 – the Europea...
How to improve the health of the Polish population. Health 2020 – the Europea...How to improve the health of the Polish population. Health 2020 – the Europea...
How to improve the health of the Polish population. Health 2020 – the Europea...
 
Aids awareness
Aids awarenessAids awareness
Aids awareness
 
Seminar on hiv
Seminar on hivSeminar on hiv
Seminar on hiv
 
seminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdfseminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdf
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 
Presentation: Launch of the Knowledge Hub on Health and Migration
Presentation: Launch of the Knowledge Hub on Health and MigrationPresentation: Launch of the Knowledge Hub on Health and Migration
Presentation: Launch of the Knowledge Hub on Health and Migration
 
Global tuberculosis report 2013 supplement
Global tuberculosis report 2013 supplementGlobal tuberculosis report 2013 supplement
Global tuberculosis report 2013 supplement
 
Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...
 
noncommunicablediseasespro1-180101054815.pdf
noncommunicablediseasespro1-180101054815.pdfnoncommunicablediseasespro1-180101054815.pdf
noncommunicablediseasespro1-180101054815.pdf
 
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxWORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
 
global health11.pptxglopal health 1234556666666
global health11.pptxglopal health 1234556666666global health11.pptxglopal health 1234556666666
global health11.pptxglopal health 1234556666666
 
World TB Day 2017 - presentation
World TB Day 2017 - presentationWorld TB Day 2017 - presentation
World TB Day 2017 - presentation
 
Presentation – The WHO European Region's public health response to refugee an...
Presentation – The WHO European Region's public health response to refugee an...Presentation – The WHO European Region's public health response to refugee an...
Presentation – The WHO European Region's public health response to refugee an...
 
Cmoathensrdkeynotespeechinfectdiseasesedited 140306043900-phpapp02
Cmoathensrdkeynotespeechinfectdiseasesedited 140306043900-phpapp02Cmoathensrdkeynotespeechinfectdiseasesedited 140306043900-phpapp02
Cmoathensrdkeynotespeechinfectdiseasesedited 140306043900-phpapp02
 
6249919.ppt
6249919.ppt6249919.ppt
6249919.ppt
 
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO
OVEARVIEW  OF NON-COMMUNICABLE DISEASES  IN LEOTHO   OVEARVIEW  OF NON-COMMUNICABLE DISEASES  IN LEOTHO
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO
 
Infectious disease control as part of prevention of cancer in developing coun...
Infectious disease control as part of prevention of cancer in developing coun...Infectious disease control as part of prevention of cancer in developing coun...
Infectious disease control as part of prevention of cancer in developing coun...
 

Recently uploaded

DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 

Recently uploaded (20)

DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 

Germany-Health statistics

  • 2. Deutschland • Germany is a densely populated and highly industrialized country with more than 82 million inhabitants. The life expectancy at birth is 77.6 years for males and 82.8 years for females. The percentage of the population aged 65 years or more is rising. Germany does not have a national health care system. The health care system is administered through several autonomous bodies and associations such as the statutory health insurance system (GKV), the association of physicians under contract with the GKV, and the hospitals association.
  • 3.
  • 4. Indicators Values POPULATION 82,727,000 % of population aged 0–14 years 13 % of population aged 65+ years 21 Crude death rate per 1000 population 11 Estimated infant mortality per 1000 live births (world health report) 3 Estimated life expectancy (world health report) 81 Life expectancy at birth (years), females 83 Life expectancy at birth (years), males 78 Hospital beds per 100 000 828 Physicians per 100 000 405
  • 5. Indicators Values SDR all causes, all ages, per 100 000 564 SDR, diseases of circulatory system, all ages, per 100 000 200 SDR, external causes of injury and poisoning, all ages, per 100 000 28 SDR, malignant neoplasms, all ages, per 100 000 157 Total health expenditure as % of GDP, WHO estimates 11 Total expenditure on health per capita 4812 All the details mentioned above are the extracts from a survey taken by Robert Koch Institute(RKI) in 2014
  • 6.
  • 7. TOP 10 CAUSES OF DEATH per 10000 population • Disease rate global rank • Coronary Heart Disease 62.93 133 • Lung Cancers 27.78 30 • Stroke 27.32 163 • Breast Cancer 21.84 32 • Prostate Cancer 15.98 93
  • 8. • Colon-Rectum Cancers 15.17 41 • Hypertension 15.05 04 • Alzheimers/Dementia 13.39 25 • Diabetes Mellitus 11.43 138 • Influenza and Pneumonia 9.86 189
  • 9.
  • 10. Social Diseases • What is a Social Disease? • A disease having it’s highest incidence among socioeconomic group of a country predisposed to it by a given set of adverse living or working conditions • Example:Prevalance of cancers and radiation related adverse effects in regions near Chernobyl and Fukushima • Simply it refers to regional diseases provoked by adverse conditions.
  • 11. PREVALENCE OF HIV IN GERMANY • Diagnoses of new HIV infections in Germany rose by 20% in the first half of 2014 compared with the first half of 2010, according to the latest figures from the Robert Koch Institute, Germany's centre for public health and disease control. Gay and bisexual men accounted for almost 60% of these new HIV diagnoses, a 30% rise from four years ago. • With a population of 82.5 million, Germany is Europe's most populous nation. Historically, HIV prevention has been relatively successful and new HIV diagnoses have tended to total under 2,000 each year for the past decade. Even though in 2014 new HIV diagnoses totalled 2,058 - the highest since 2002 - this compares with 7,000 new HIV diagnoses in 2003 in the United Kingdom, the third most populous country in Europe with around 60 million inhabitants
  • 12.
  • 13. • The Institute also reports on the cities with the highest HIV incidence rates between July 2004 and June 2005. Cologne, with an incidence rate of 12.42 per 100,000 population had the highest rate. However, the highest absolute numbers were seen in Germany's two biggest cities, Berlin and Hamburg, which had incidence rates of 10 per 100,000 and 9.57 per 100,000, respectively. Other cities with high HIV incidence included Munich, Frankfurt and Düsseldorf.
  • 14. • According to the latest estimate, there were a total of 436,500 new cancer cases in Germany in 2004. The most common cancer in men is prostate cancer with over 58,000 new cases per annum, followed by colorectal and lung cancer. In women, breast cancer remains the most common cancer with an estimated 57,000 new cases every year, also followed by colorectal cancer. These and further findings on selected cancer sites can be found in the current brochure on "Cancer in Germany“ which is regularly published by rki. • In addition, the RKI made cancer-prevalence estimates and calculated current morbidity and mortality risks at the federal level for the first time • According to these figures, the 5-year partial prevalence - i.e. the total number of cancer patients diagnosed over the past five years who are currently still living - exceeds 600,000 in men; the figure is about the same among women. Prevalence of Cancers in Germany
  • 15.
  • 16. • Here, too, the most common cancers are prostate cancer in men and breast cancer in women. The lifetime risk of developing cancer, which is more related to the individual, is estimated to be higher among men (48.5%) than among women (40.3%) • In roughly rounded figures, therefore, about every day, a person in Germany develops cancer in the course of their lives • One in four men and one in five women die of cancer.
  • 17.
  • 18. • In Germany, crude death rates from cancer were in excess of 300 deaths per 100 000 inhabitants in the regions of Sachsen-Anhalt, Chemnitz, Saarland, Mecklenburg-Vorpommern, Arnsberg and Düsseldorf • By contrast, a relatively low crude death rate was recorded in the southern German region of Tübingen (220 deaths per 100 000 inhabitants). • Across the EU Member States, there was a large cluster of relatively high death rates from breast cancer in the centre of the EU covering much of Germany, Denmark, the Benelux countries, eastern France, northern Italy, eastern Austria and western Hungary; high rates were also recorded in some parts of the United Kingdom.
  • 19. • The HIV epidemic in Germany can be characterized as a concentrated epidemic. The most affected population groups are • MSM (estimated number of MSM living with HIV by the end of 2011: 46,500) • Migrants originating from HIV high prevalence countries (estimated number of migrants living with HIV by end of 2011: 9,000) • IDU (estimated number of IDU living with HIV by end of 2011: 6,800 [including former IDU]) HIV INFECTION
  • 20. Men 59000 Women 14000 Among these: Children 200 ……by mode of transmission Homosexual contact 46500 Heterosexual contact 10500 IV drug use 6500 Blood transfusion 450 Mother to Children 420 Persons living with HIV 73000
  • 21. • Currently, the incidence is highest among MSM. It is estimated that 74 % of the HIV infections acquired in Germany are through male homosexual contact, 20% through heterosexual contact, 6% associated with injecting drug use. Less than 1% of infections are due to mother-to-child transmission. • The number of newly diagnosed HIV infections in IDU in Germany has been continuously declining since 1997. • Data modelling suggests that HIV incidence among MSM started to decline as early as 2007. HIV prevalence among this group is estimated between 5.0% and 7.5% • Approximately half of the heterosexually acquired HIV infections in Germany are reported in migrants originating from high prevalence countries with a generalized epidemic (predominantly from countries in western Sub-Saharan Africa)
  • 22.
  • 23. • Over the past 50 years, the reduction of mortality from CVD in Germany has followed a similar trend as the OECD average, reaching 310 per 100 000 population, 4% higher than the OECD average of 299 in 2011 • the number of patients with end-stage kidney failure (ESKF), often caused by diabetes and hypertension, at 87 per 100 000 population in 2000, is also lower than the OECD average of 101 in 2011 CARDIOVASCULAR DISEASES
  • 24.
  • 25. • The rate of smoking, one of the risk factors for CVD, was 21.9% for adults in 2011, higher than the OECD average of 20.9%, and youth smoking was 22.4%, compared to an OECD average of 19.5%, but the most recent national data show improvements (20.9% and 18.5% respectively in 2013). • The rate of overweight, at 36.7%, is also higher than the OECD average of 34.6%. On the other hand, the rate of obesity, at 14.7%, is much lower than the OECD averages of 18.0% but it is increasing (15.7% in 2013). • The reported prevalence of high cholesterol levels and high blood pressure is 24.6% and 26.0% each, again higher than the OECD average of 18.0% and 25.6%, respectively. • Spending on prevention, however, is 3.4% of the current health expenditure and higher than the OECD average of 2.9%.
  • 26. DISABLED PERSONS IN GERMANY • In 2013, 10.2 million people with an officially recognised disability - on the basis of microcensus results - were living in Germany • On average, more than one in eight inhabitants (13%) was disabled • More than half of them (52%) were men. • The majority, that is, roughly 7.5 million people were severely disabled, while 2.7 million people suffered from a moderate disability
  • 27. Severely disabled people (in 2013) 7,548,965 Men 51.0% Women 49% >65 Years 53.4% Age groups Disability rate 1-20 years of age 8% 20-30 6% 30-45 15% 45-65 6.8% >65 25%
  • 28. Overview of the facilities, organizations and support available for people with disabilities in Germany... • German law (Grundgesetz) forbids discrimination on the basis of physical or mental disability. • The Social Welfare Code IX (SGBIX), which came in to force in April 2001, is based on the idea of equal opportunities and participation rather than merely welfare • It focuses on rehabilitation and access for disabled people and stipulates levels of support depending on measurement of the degree of disability
  • 29. • According to the German Federal Statistical Office, or Destatis, the impact of the disability on the participation in the life of society is graded from 20 to 100. • People are classified as severely disabled in Germany if a pension office has determined a degree of disablement of 50 or more. • As easily disabled persons are referred to with a degree of disability of less than 50.
  • 30. There is a great deal of support available to disabled people (behinderter Menschen) in Germany, from general counselling to specific institutions such as: • Advice centres • Early support centres for children (Frühförderung) • Integrated kindergartens • Special kindergartens (Sonderkindergarten or Förderkindergarten) • Special Schools (Sonderschulen) • Special professional schools (Berufsschulen), for instance for deaf pupils
  • 31. • Apprenticeships for visually impaired and deaf people (Ausbildungsplaetze) • Employment integration support • Care and accommodation grants for disabled people • Workshops for disabled people (Werkstätten für behinderte Menschen) • Transport services (Fahrdienste)
  • 32. To conclude…… • Approximately 15% of the NATION’S INCOME is used for HEALTH CARE MANAGENMENT every year • At present around 2.2 million people are employed in outpatient care • In Germany, there are currently more than 200 inpatient hospices, more than 250 palliative units in hospitals and around 1,500 outpatient hospice services • In 2013 health expenses amounted to EUR 314.9 billion. The largest item is made up of medical followed by care services • In an international comparison Germany ranges with per capita expenses of around EUR 3,800 per year for health in the LIST OF EUROPEAN NATIONS Health care is one of the industries with the highest sales revenues in Germany. 6.1 million employees worked in the health economy (including wellness, fitness etc.) in 2012
  • 33. References: • Germany’s health profile -http://www.worldlifeexpectancy.com/country-health- profile/Germany • Causes of deaths in Germany- https://www.destatis.de/EN/FactsFigures/SocietyState/Health/CausesDeath/Causes Death.html • Prevalence of various diseases in Germany- http://www.healthdatanavigator.eu/national/Germany • People with disabilities in Germany-https://www.angloinfo.com/germany/how- to/germany-healthcare-people-with-disabilities • http://www.bmas.de/EN/Our-Topics/Participation-of-Persons-with- Disabilities/disability-policy.html • Robert Koch Institute- http://www.rki.de/EN/Content/Health_Monitoring/health_monitoring_node.html

Editor's Notes

  1. MSM-Men having sexual intercourse with Men IDU-Intravenous Drug Users Epidemic-is the slow spread of infectious disease to a large number of people in a given population within a short period of time, usually two weeks or less An epidemic in which HIV or another pathogen represents > 5% in any sub-population at higher risk of infection—e.g., druginjectors, sex workers, homosexual men-Concentrated epidemic
  2. OECD-Organisation for Economic Co-operation and Developement